Tranexamic acid: A novel oral formulation for the treatment of heavy menstrual bleeding

Women's Health

Volumn 7, Issue 2, 2011, Pages 151-158

  Lukes, Andrea S ^c   Kouides, Peter A ^a   Moore, Keith A ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b Xanodyne Pharmaceuticals Inc   (United States)

^c Carolina Women's Research and Wellness Center   (United States)

Author keywords

antifibrinolytic; heavy menstrual bleeding; Lysteda ; menorrhagia; tranexamic acid

Indexed keywords

LYSTEDA; MOXIFLOXACIN; PLACEBO; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANEMIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BACKACHE; DIARRHEA; DIZZINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTROL; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; FIBRINOLYSIS; FOLLITROPIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; LIMB PAIN; MAXIMUM PLASMA CONCENTRATION; MENORRHAGIA; MIGRAINE; MULTIPLE CYCLE TREATMENT; MUSCLE CRAMP; MUSCLE SPASM; MUSCULOSKELETAL PAIN; MYALGIA; NAUSEA; PHARMACODYNAMICS; POSTMARKETING SURVEILLANCE; QT PROLONGATION; QUALITY OF LIFE; SIDE EFFECT; SINUS HEADACHE; SKIN BLEEDING; TIME TO MAXIMUM PLASMA CONCENTRATION; UPPER RESPIRATORY TRACT INFECTION; VON WILLEBRAND DISEASE; WOMEN'S HEALTH;

ANTIFIBRINOLYTIC AGENTS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MENORRHAGIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 79952790823     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.9     Document Type: Article

References (20)

1. Lethaby A, Farquhar C, Cooke I: Antifbrinolytics for heavy menstrual bleeding. Cochrane Database Syst. Rev. (4), CD000249 (2000).
2. Dockeray CJ, Sheppard BL, Daly L, Bonnar J: The fbrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur. J. Obstet. Gynecol. Reprod. Biol. 24(4), 309-318 (1987). (Pubitemid 17065272)
3. Fraser IS, Porte RJ, Kouides PA, Lukes AS: A beneft-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf. 31(4), 275-282 (2008). (Pubitemid 351441576)
4. Rainsford SG, Jouhar AJ, Hall A: Tranexamic acid in the control of spontaneous bleeding in severe haemophilia. Thromb. Diath. Haemorrh. 30(2), 272-279 (1973).
5. Federici AB, Sacco R, Stabile F, Carpenedo M, Zingaro E, Mannucci PM: Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective ana lysis of 63 cases. Haemophilia 6(2), 71-77 (2000) (Pubitemid 30166826)
6. Tranexamic acid (Lysteda) for treatment of menorrhagia. Med. Lett. Drugs Ther. 52(1342), 54-55 (2010).
7. Fraser IS, Porte RJ, Kouides PA, Lukes AS: A beneft-risk review of systemic haemostatic agents: part 1: in major surgery. Drug Saf. 31(3), 217-230 (2008). (Pubitemid 351311577)
8. Nelson AL, Teal SB: Medical therapies for chronic menorrhagia. Obstet. Gynecol. Surv. 62(4), 272-281 (2007). (Pubitemid 46555922)
9. Kouides PA, Kadir RA: Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects. J. Thromb. Haemost. 5 (Suppl. 1), 1175-1182 (2007).
10. Moore KA, Callahan TS, Maison-Blanche P et al.: Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding. Expert Opin. Pharmacother. 11(14), 2281-2290 (2010).
11. Moore KA, Young J, Heasley R, Boesing S: Noncompartmental single dose pharmacokinetics, bioavailability and bioequivalence to two novel nonimmediate release oral tranexamic acid products in fed and fasting healthy women. Presented at: American College of Clinical Pharmacy Congress. Phoenix, AZ, USA, 5-9 April 2008.
12. Moore KA, Morin I, Marenco T, Lavigne J, Morelli G: Pharmacokinetic studies of two novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding. Am. J. Ther. doi: 10.1097/MJT.0b013e318205427a (2011) (Epub ahead of print).
13. Lukes AS, Moore KA, Muse KN et al.: Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet. Gynecol. 116(4), 865-875 (2010).
14. Lukes AS, Waldbaum A, Eder SE, Moore KA, Shangold GA: A novel, oral tranexamic acid formulation for heavy menstrual bleeding: a dose-response ana lysis. Presented at: American College of Obstetricians and Gynecologists Congress. San Francisco, CA, USA, 15-19 May 2010.
15. Fraser IS, Warner P, Marantos PA: Estimating menstrual blood loss in women with normal and excessive menstrual fuid volume. Obstet. Gynecol. 98(5 Pt 1), 806-814 (2001). (Pubitemid 33042549)
16. Lukes AS, Muse K, Richter HE, Moore KA, Patrick DL: Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding. Curr. Med. Res. Opin. 26(11), 2673-2678 (2010).
17. Bushnell DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL: Menorrhagia Impact Questionnaire: assessing the infuence of heavy menstrual bleeding on quality of life. Curr. Med. Res. Opin. 26(12), 2745-2755 (2010).
18. Lukes AS, Gersten JK, Mabey R, Kroll R, Moore KA, Patrick DL: Novel oral tranexamic acid formulation for heavy menstrual bleeding: effect on quality of life. Presented at: American College of Obstetricians and Gynecologists Congress. San Francisco, CA, USA, 15-19 May 2010.
19. Muse K, Gersten JK, Waldbaum A, Mabey R, Lukes AS, Moore KA: Long-term quality of life and safety of a new tranexamic acid menorrhagia treatment. Presented at: American Society for Reproductive Medicine Congress. Denver, CO, USA, 23-27 October 2010.
20. Kouides PA, Byams VR, Philipp CS et al.: Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br. J. Haematol. 145(2), 212-220 (2009).